237 related articles for article (PubMed ID: 37065370)
1. The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature.
Nduma BN; Mofor KA; Tatang J; Ekhator C; Ambe S; Fonkem E
Cureus; 2023 Mar; 15(3):e36148. PubMed ID: 37065370
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Cannabis and Its Potential Protective Role Against Inflammatory Bowel Disease: A Scoping Review.
Nso N; Nyabera A; Nassar M; Alshamam MS; Sumbly V; Vest M; Patel N; Ojong G; Rizzo V
Cureus; 2021 Oct; 13(10):e18841. PubMed ID: 34804696
[TBL] [Abstract][Full Text] [Related]
4. Cannabis for the treatment of Crohn's disease.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
[TBL] [Abstract][Full Text] [Related]
5. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
6. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].
Volz MS; Siegmund B; Häuser W
Schmerz; 2016 Feb; 30(1):37-46. PubMed ID: 26809974
[TBL] [Abstract][Full Text] [Related]
9. Cannabis for inflammatory bowel disease.
Naftali T; Mechulam R; Lev LB; Konikoff FM
Dig Dis; 2014; 32(4):468-74. PubMed ID: 24969296
[TBL] [Abstract][Full Text] [Related]
10. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.
Storr M; Devlin S; Kaplan GG; Panaccione R; Andrews CN
Inflamm Bowel Dis; 2014 Mar; 20(3):472-80. PubMed ID: 24407485
[TBL] [Abstract][Full Text] [Related]
11. Cannabis for the treatment of ulcerative colitis.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
[TBL] [Abstract][Full Text] [Related]
12. Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.
Naftali T; Bar-Lev Schleider L; Dotan I; Lansky EP; Sklerovsky Benjaminov F; Konikoff FM
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1276-1280.e1. PubMed ID: 23648372
[TBL] [Abstract][Full Text] [Related]
13. Cannabis use amongst patients with inflammatory bowel disease.
Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease: What Can We Learn From Randomized and Nonrandomized Studies?
Doeve BH; van de Meeberg MM; van Schaik FDM; Fidder HH
J Clin Gastroenterol; 2021 Oct; 55(9):798-809. PubMed ID: 32675631
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Use of Cannabis in Inflammatory Bowel Disease.
Ahmed W; Katz S
Gastroenterol Hepatol (N Y); 2016 Nov; 12(11):668-679. PubMed ID: 28035196
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid Therapeutic Effects in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Vinci A; Ingravalle F; Bardhi D; Cesaro N; Frassino S; Licata F; Valvano M
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289701
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Hasenoehrl C; Storr M; Schicho R
Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):329-337. PubMed ID: 28276820
[TBL] [Abstract][Full Text] [Related]
19. Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease.
Bogale K; Raup-Konsavage W; Dalessio S; Vrana K; Coates MD
Med Cannabis Cannabinoids; 2021; 4(2):97-106. PubMed ID: 35224429
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
